News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
781,901 Results
Type
Article (30500)
Company Profile (14)
Press Release (751385)
Multimedia
Podcasts (119)
Webinars (14)
Section
Business (263277)
Career Advice (3990)
Deals (39294)
Drug Delivery (190)
Drug Development (88507)
Employer Resources (192)
FDA (18542)
Job Trends (16840)
News (389909)
Policy (37618)
Tag
2027 BioCapital Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (2984)
Accelerated approval (37)
ADA (10)
Adcomms (42)
Allergies (85)
Alliances (56105)
ALS (57)
Alzheimer's disease (1353)
Antibody-drug conjugate (ADC) (236)
Approvals (18263)
Artificial intelligence (193)
ASCO (128)
Autoimmune disease (202)
Automation (14)
Bankruptcy (387)
Belgium (13)
Best Places to Work (12250)
BIO (37)
Biologics (17)
BIOSECURE Act (13)
Biosimilars (111)
BioSpace Insights (116)
Biotechnology (9)
Bispecific (13)
Bladder cancer (91)
Brain cancer (22)
Breast cancer (286)
Cancer (2429)
Cardiovascular disease (190)
Career advice (3417)
Career pathing (49)
CAR-T (231)
CDC (65)
CDMO (101)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (454)
Cervical cancer (16)
Clinical research (71608)
Collaboration (465)
Commercialization (10)
Compensation (244)
Complete response letters (74)
COVID-19 (3041)
CRISPR (36)
CRO (1)
C-suite (215)
Cystic fibrosis (92)
Data (3237)
Decentralized trials (2)
Denatured (46)
Depression (55)
Dermatology (93)
Diabetes (233)
Diagnostics (6649)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (48)
Drug discovery (85)
Drug pricing (169)
Drug shortages (27)
Duchenne muscular dystrophy (118)
Earnings (97985)
Editorial (50)
Employer branding (24)
Employer resources (166)
ESMO (181)
Events (127689)
Executive appointments (191)
Eye disease (7)
FDA (19778)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (396)
Gene editing (69)
Generative AI (22)
Gene therapy (248)
GLP-1 (750)
Government (5401)
Grass and pollen (5)
Guidances (303)
Healthcare (20671)
Hematology (73)
HIV (55)
Huntington's disease (24)
IgA nephropathy (65)
Immunology and inflammation (115)
Immuno-oncology (42)
Indications (92)
Infectious disease (3245)
Inflammatory bowel disease (161)
Inflation Reduction Act (14)
Influenza (81)
Intellectual property (87)
Interviews (797)
IPO (17436)
IRA (54)
Job creations (4733)
Job search strategy (2706)
JPM (25)
Kidney cancer (18)
Kidney disease (43)
Labor market (51)
Layoffs (512)
Leadership (48)
Legal (9488)
Licensing (17)
Liver cancer (80)
Longevity (8)
Lung cancer (378)
Lung diease (5)
Lymphoma (304)
Machine learning (8)
Management (65)
Manufacturing (389)
Marketing (6)
MASH (67)
Medical affairs (1)
Medical device (14205)
Medtech (14264)
Mergers & acquisitions (21873)
Metabolic disorders (694)
mRNA (223)
Multiple sclerosis (104)
Multispecific (1)
NASH (18)
Netherlands (4)
Neurodegenerative disease (115)
Neuropsychiatric disorders (30)
Neuroscience (1854)
NextGen: Class of 2026 (7247)
Non-profit (5045)
Now hiring (42)
Obesity (389)
Opinion (330)
Ovarian cancer (100)
Pain (75)
Pancreatic cancer (118)
Parkinson's disease (97)
Partnered (16)
Patents (207)
Patient advocacy (1)
Patient recruitment (127)
Patient selection (10)
Peanut (44)
People (63684)
Peptides (11)
Pharmaceutical (7)
Pharmacy benefit managers (23)
Phase 1 (22021)
Phase 2 (31260)
Phase 3 (23892)
Pipeline (4737)
Policy (299)
Postmarket research (2907)
Preclinical (9299)
Press Release (72)
Prostate cancer (116)
Psychedelics (37)
Radiopharmaceuticals (234)
Rare diseases (548)
Real estate (7080)
Recruiting (74)
Regenerative medicine (4)
Regulatory (25546)
Reports (41)
Research institute (2653)
Resumes & cover letters (634)
Rett syndrome (10)
RNA editing (9)
RSV (57)
Schizophrenia (59)
Series A (58)
Series B (39)
Service/supplier (1)
Sickle cell disease (45)
Special edition (14)
Spinal muscular atrophy (158)
Sponsored (35)
Startups (4165)
State (1)
Stomach cancer (13)
Substance use disorders (3)
Supply chain (46)
Switzerland (1)
Tariffs (47)
The Weekly (72)
Vaccines (991)
Venture capital (33)
Weight loss (294)
Wet AMD (3)
Women's health (52)
Worklife (23)
Date
Today (30)
Last 7 days (214)
Last 30 days (724)
Last 365 days (8332)
2026 (6724)
2025 (8892)
2024 (26308)
2023 (42561)
2022 (53926)
2021 (58719)
2020 (57661)
2019 (51334)
2018 (38957)
2017 (34568)
2016 (34810)
2015 (41097)
2014 (35994)
2013 (31852)
2012 (34001)
2011 (34209)
2010 (35433)
Location
Africa (870)
Alabama (45)
Alaska (6)
Arizona (246)
Arkansas (11)
Asia (45532)
Australia (7380)
California (4703)
Canada (1525)
China (562)
Colorado (214)
Connecticut (239)
Delaware (182)
Europe (102882)
Florida (612)
Georgia (158)
Hawaii (1)
Idaho (65)
Illinois (536)
India (41)
Indiana (309)
Iowa (3)
Japan (216)
Kansas (108)
Kentucky (15)
Louisiana (22)
Maine (61)
Maryland (669)
Massachusetts (3477)
Michigan (174)
Minnesota (358)
Mississippi (1)
Missouri (39)
Montana (24)
Nebraska (22)
Nevada (43)
New Hampshire (59)
New Jersey (1686)
New Mexico (19)
New York (1355)
North Carolina (890)
North Dakota (7)
Northern California (2503)
Ohio (172)
Oklahoma (9)
Oregon (31)
Pennsylvania (1092)
Puerto Rico (5)
Rhode Island (13)
South America (1300)
South Carolina (18)
Southern California (1913)
Tennessee (43)
Texas (627)
United States (18528)
Utah (125)
Vermont (1)
Virginia (65)
Washington D.C. (24)
Washington State (457)
West Virginia (3)
Wisconsin (34)
781,901 Results for "19".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WeGuide secures $1.9 Million to create a world-first platform in developing commercial multi-modal biomarkers
WeGuide Pty Ltd will receive A$1.9 million to build a world first platform in developing commercial multi-modal biomarkers. Building their first use case with NeuRA on mobility recovery, the platform accelerates regulatory-approved biomarker development for researchers, health organisations and pharmaceutical companies working to bring precision medicine tools to patients and trial participants.
September 24, 2026
·
1 min read
COVID-19
FDA assembles vaccine experts to update COVID-19 formulation
The FDA will convene its vaccines advisory panel to discuss seasonal COVID-19 vaccines—a surprise move after Health Secretary and vaccine skeptic Robert F. Kennedy, Jr. overhauled a separate vaccine committee.
May 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Novo Nordisk A/S - share repurchase programme - October 19, 2026
October 19, 2026
·
2 min read
Press Releases
Conavi Medical Announces New Grants of Stock Options - October 19, 2026
October 19, 2026
·
4 min read
Manufacturing
Pharma manufacturing projected to create 19,000 jobs through 2034
The forecast makes pharma one of the fastest-growing manufacturing industries in the U.S.
June 3, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - October 19, 2026
October 19, 2026
·
2 min read
Press Releases
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
October 8, 2026
·
6 min read
Press Releases
Regeneron Announces Investor Conference Presentations - August 19, 2026
August 19, 2026
·
1 min read
RNA editing
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B
For an investment of up to $1.9 billion, Eli Lilly will be able to use Ascidian Therapeutics’ platform that removes mutated exons from mRNA molecules, avoiding the expression of disease-causing proteins.
June 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 19, 2026
October 19, 2026
·
4 min read
1 of 78,191
Next
